Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06406205 |
| Consolidated Lead Sponsor | Qilu Pharmaceutical Co |
| Therapeutic Condition Cohort | Immunology, Rheumatology, and Dermatology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 270 participants (ESTIMATED) |
| Registered Start Date | 2023-12-25 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Anhui Provincial Hospital | Hefei, China | Open Hospital Dossier -> |
| The Second Affiliated Hospital of Anhui Medical University | Hefei, China | Open Hospital Dossier -> |
| Peking University First Hospital | Beijing, China | Open Hospital Dossier -> |
| Fujian Medical University Union Hospital | Fuzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.